CELZ — Creative Medical Technology Holdings Balance Sheet
0.000.00%
Last trade - 00:00
- $4.77m
- -$4.24m
- $0.01m
- 45
- 26
- 28
- 24
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.089 | 0.098 | 10.7 | 18.4 | 9.99 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.006 | 0 | 0.002 | 0 | — |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.094 | 0.098 | 10.7 | 18.7 | 10.3 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 0.531 | 0.718 | 11.3 | 19.2 | 10.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8.6 | 40.5 | 1.05 | 3.32 | 0.371 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 8.6 | 40.5 | 1.05 | 3.32 | 0.371 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | -8.07 | -39.8 | 10.2 | 15.9 | 10.3 |
Total Liabilities & Shareholders' Equity | 0.531 | 0.718 | 11.3 | 19.2 | 10.7 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |